Nifedipine and molsidomine tablets are extremely photolabile drug preparations, even at cool room light. Compared to solutions the light spectrum responsible for photodegradation is moved towards the long-wavelength range corresponding to the bathochromic shift of light absorption in
the solid state. In the case of nifedipine tablets light up to 500 nm, especially the range between 400–420 nm, is degrading. Molsidomine tablets are affected only by ultraviolet light, but not by visible light. In both cases light penetrates less than 1 mm into the tablets. For nifedipine
tablets the exact penetration depth could be determined due to the discolouration of the drug substance upon irradiation. It varied from 360 μm to 880 μm depending on the drug content. Since the decomposition products of nifedipine act as photostabilizers by spectral overlay, light penetration
and photodegradation in nifedipine tablets are limited. The formation of gaseous and liquid decomposition products in molsidomine tablets enhances photodegradation. Changes of the tablet structure as well as dissolution and migration processes are discussed. Furthermore the degradation products
do not photostabilize the drug substance due to the missing light absorption above 300 nm.
No References for this article.
No Supplementary Data.
No Article Media
Document Type: Research Article
Department of Pharmaceutical Technology, Ludwig-Maximilians-University Munich, Munich, Germany
Department of Pharmaceutical Technology, Ludwig-Maximilians-University Munich, Lindenweg 8, Wörgl, A-6300, Austria
Publication date: September 1, 2003
More about this publication?
Pharmazie is a leading journal in the field of pharmaceutical sciences. As a peer-reviewed scientific journal, Pharmazie is regularly indexed in the relevant databases like Web of science, Journal Citation Reports and many others. The journal is open for submissions from the whole spectrum of pharnaceutical sciences including Pharmaceutical Chemistry, Experimental and Clinical Pharmacology, Drug Analysis, Pharmaceutics, Pharmaceutical Biology, Clinical Pharmacy etc.
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Ingenta Connect is not responsible for the content or availability of external websites